Predictive Oncology, Inc.

Predictive Oncology, Inc.

Predictive Oncology, Inc.

Overview
Date Founded

2013

Headquarters

2915 COMMERS DRIVE SUITE 900 EAGAN MN 55121

Type of Company

Public

Employees (Worldwide)

32

Industries

Medical Products & Equipment
Hospitals & Patient Services
Medical Support Services

Company Description

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.

Contact Data
Trying to get in touch with decision makers at Predictive Oncology, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Chief Financial Officer & Principal Accounting Officer

Vice President of Sales & Marketing

Head of External Business Development-Tumorgenesis, Inc

President-Tumorgenesis, Inc

Vice President-International Sales

Global Vice President-Sales & Marketing

Board of Directors

Former Chief Executive Officer at Anika Therapeutics, Inc.

President, Chief Executive Officer & Director at Predictive Oncology, Inc.

Head of External Business Development-Tumorgenesis, Inc at Predictive Oncology, Inc.

Chief Financial Officer & Secretary at Dakshidin Corp.

Independent Director at Predictive Oncology, Inc.

Founder at SunStone Consulting LLC

Professor at Southern California University of Health Sciences

Paths to Predictive Oncology, Inc.
Potential Connections via
Relationship Science
You
Predictive Oncology, Inc.
Recent Transactions
Details Hidden

Predictive Oncology, Inc. purchases Soluble Therapeutics, Inc. from InventaBiotech, Inc.

Details Hidden

Predictive Oncology, Inc. raised money in a private placement transaction

Details Hidden

Predictive Oncology, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Transaction Advisors
Investment Advisor

Advised onPredictive Oncology, Inc. raised money in a private placement transaction

Escrow Agent

Advised onPredictive Oncology, Inc. issued USD Units

Underwriter

Advised onPredictive Oncology, Inc. issued USD Units

Legal Advisor

Advised onPredictive Oncology, Inc. issued USD Units Consisting of Common Stock and Warrants

Founder

Advised onPredictive Oncology, Inc. issued USD Units Consisting of Common Stock and Warrants

Advisors & Consultants
Publicist

Partner-IR Strategy & Operations at Hayden IR, Inc.

Publicist

Professional at MoneyInfo LLC

Publicist

Account Director-Investor Relations at KCSA Strategic Communications

Clients

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

The National Alopecia Areata Foundation (NAAF) serves the community of people affected by an autoimmune skin disease called alopecia areata that results in hair loss and emotional pain. NAAF is a 501(c)(3) nonprofit organization founded in 1981 and headquartered in San Rafael, CA. NAAF supports research to find a cure or acceptable treatment for alopecia areata, supports those with the disease, and educates the public about alopecia areata.

Key Stats and Financials As of 2019
Market Capitalization
$12.7M
Total Enterprise Value
$12.9M
Earnings Per Share
$-6.86
Revenue
$1.41M
Enterprise Value / Sales
9.14x
TEVNet Income
-0.67x
Debt TEV
0.43x
EBITDAMargin
-925.9%
Total Debt
$5.53M
EBITDA
$-13.1M
Total Equity
$11.2M
Net Profit
$-19.4M
Three Year Compounded Annual Growth Rate Of Revenue
45.69%
Non-Profit Donations & Grants
Investments
Details Hidden

Medisyn Technologies, Inc. develops novel pharmaceuticals, nutraceuticals, and animal health products. The firm engages in the development of pre-qualified proprietary drug compounds. Its Forward Engineering platform is focused on predicting the behavior of molecules from topology. The company was founded in 1999 and is headquartered in Minnetonka, MN.

Investors
Details Hidden

BHA is a group of investors seeking to invest in high-growth early-stage companies. The firm is looking for capital-efficient businesses that can reach profitability with less than $5M of equity investment and provide at least a tenfold return on the investment within five years.The firm targets the companies operating in the fields of medical devices, IT, consumer products, business products, specialty materials, internet and aviation. Single investments generally range from $250,000 - $150,0000. They can fund a portion of the round and syndicate the deal with other angel groups or early-stage venture funds.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Predictive Oncology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Predictive Oncology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Predictive Oncology, Inc..